NK1 antagonists
Details for Australian Patent Application No. 2003220215 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/363,761 13.03.02 US
6 November 2003 Application Open to Public Inspection
Published as AU-B-2003220215
4 January 2007 Application Accepted
Published as AU-B-2003220215
17 May 2007 Standard Patent Sealed
8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003220216-1,2-Dihydropyrazol-3-ones as cytokine mediators
2003220214-DUAL-INPUT DIFFERENTIAL PLANETARY GEAR TRANSMISSION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser